ML
MRK icon

McAdam LLC’s Merck MRK Stock Holding History

McAdam LLC’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.26M Buy
25,372
+1,376
+6% +$161K 0.13% 80
2026
Q1 		$2.89M Buy
23,996
+3,481
+17% +$402K 0.13% 88
2025
Q4 		$2.16M Buy
20,515
+91
+0.4% +$8.54K 0.1% 100
2025
Q3 		$1.71M Buy
20,424
+271
+1% +$22.3K 0.08% 107
2025
Q2 		$1.6M Buy
20,153
+1,577
+8% +$125K 0.09% 112
2025
Q1 		$1.67M Sell
18,576
-88
-0.5% -$8.22K 0.1% 100
2024
Q4 		$1.86M Buy
18,664
+713
+4% +$73.5K 0.1% 106
2024
Q3 		$2.04M Buy
17,951
+1,218
+7% +$145K 0.11% 89
2024
Q2 		$2.07M Buy
16,733
+578
+4% +$74.5K 0.12% 82
2024
Q1 		$2.13M Buy
16,155
+7
+0% +$863 0.14% 80
2023
Q4 		$1.76M Buy
16,148
+767
+5% +$79.6K 0.13% 81
2023
Q3 		$1.58M Buy
15,381
+765
+5% +$82.5K 0.13% 84
2023
Q2 		$1.69M Buy
14,616
+5,167
+55% +$587K 0.14% 85
2023
Q1 		$1.01M Buy
9,449
+5,097
+117% +$550K 0.09% 110
2022
Q4 		$334K Sell
4,352
-3,275
-43% -$335K 0.03% 135
2022
Q3 		$657K Buy
7,627
+2,779
+57% +$248K 0.07% 115
2022
Q2 		$442K Buy
4,848
+574
+13% +$50.9K 0.05% 143
2022
Q1 		$351K Sell
4,274
-78
-2% -$6.15K 0.03% 147
2021
Q4 		$334K Buy
4,352
+205
+5% +$16.3K 0.03% 135
2021
Q3 		$311K Sell
4,147
-231
-5% -$17.6K 0.03% 130
2021
Q2 		$337K Buy
4,378
+1,009
+30% +$75K 0.04% 127
2021
Q1 		$248K Buy
3,369
+376
+13% +$27.7K 0.04% 141
2020
Q4 		$243K Buy
+2,993
New +$229K 0.04% 140
2018
Q4 		– Sell
-1,417
Closed -$97K – 413
2018
Q3 		$97K Buy
1,417
+409
+41% +$26.1K 0.04% 108
2018
Q2 		$58K Buy
1,008
+268
+36% +$15.1K 0.02% 136
2018
Q1 		$38K Buy
+740
New +$40K 0.02% 179

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

McAdam LLC's MRK Position: Q2 2026 in Review

McAdam LLC increased its Merck (MRK) stake by 5.7% in Q2 2026, buying an estimated $161K and bringing the position to 25,372 shares worth $3.26M. The position accounts for 0.13% of the portfolio, ranked #80.

McAdam LLC first reported a position in MRK in Q1 2018 and has held it in 26 quarters since. 3,829 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • McAdam LLC held 25,372 shares of Merck worth $3.26M as of Q2 2026.
  • McAdam LLC bought 1,376 Merck shares in Q2 2026, an estimated $161K.
  • Merck made up 0.13% of McAdam LLC's portfolio in Q2 2026, its #80 holding.
  • McAdam LLC first reported a position in Merck in Q1 2018 and has held it in 26 quarters since.
  • 3,829 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on McAdam LLC's 13F filing for Q2 2026, filed 4 Aug 2026.